Highline Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-158,669	Closed	-$11.6M	–	35
2018 Q4	$11.6M	Buy	+158,669	New	+$11.6M	0.78%	31